HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction. [electronic resource]
Producer: 20151009Description: 7201 p. digitalISSN:- 2045-2322
- Antioxidant Response Elements -- genetics
- Breast Neoplasms -- drug therapy
- Cell Line
- DNA-Binding Proteins -- genetics
- Doxorubicin -- pharmacology
- Drug Resistance, Neoplasm -- genetics
- Female
- Gene Expression Regulation, Neoplastic -- drug effects
- HEK293 Cells
- Heme Oxygenase-1 -- genetics
- Humans
- MCF-7 Cells
- Multidrug Resistance-Associated Proteins -- genetics
- NF-E2-Related Factor 2 -- genetics
- Paraquat -- pharmacology
- Receptor, ErbB-2 -- genetics
- Transcription, Genetic -- drug effects
- Transcriptional Activation -- drug effects
- Tumor Cells, Cultured
- Up-Regulation -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.